FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Food and Drug Administration approved Vertex Pharmaceuticals' non-opioid painkiller pill, a new alternative for pain ...
FDA Approves the First Non-Opioid Pain Drug in 20 Years
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Discover Magazine3h
FDA Approves Opioid Alternative for Pain Relief That Is Non-Addictive
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
MIT Technology Review28d
Stem-cell therapies that work: 10 Breakthrough Technologies 2025
After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.
Missoulian1d
FDA approves new painkiller that shows promise and challenges of opioid alternatives
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...
pharmaphorum5d
Vertex buys diabetes cell therapy rival ViaCyte for $320m
Vertex' therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose. The aim is to replace the pancreatic tissue ...
AFP18h
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England
Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...
C&EN2d
Pain meets precision medicine
If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...
pharmaphorum5d
FDA fast tracks type 1 diabetes cell therapy from Vertex
Vertex Pharma has made its name ... The therapy takes the form of stem cell-derived human pancreatic islet cells, which secrete insulin in the body in response to rising blood glucose.